Patents Represented by Attorney Raymond N. Nimrod

Find this attorney in the Justia Lawyer Directory

  • Prevention of ovarian cancer by administration of a Vitamin D compound
    Patent number: 7053074
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
    Type: Grant
    Filed: January 18, 2002
    Date of Patent: May 30, 2006
    Assignee: New Life Pharmaceuticals, Inc.
    Inventors: Gustavo C. Rodriguez, Regina Salas Whitaker
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6977250
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: September 17, 2001
    Date of Patent: December 20, 2005
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of products that induce transforming growth factor-&bgr; and/or apoptosis in the ovarian epithelium
    Patent number: 6765002
    Abstract: The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of increasing TGF-&bgr; expression in the ovarian epithelium. HRT and OCP regimens comprising such compositions and methods are disclosed.
    Type: Grant
    Filed: March 21, 2000
    Date of Patent: July 20, 2004
    Assignee: Gustavo Rodriguez
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
    Patent number: 6511970
    Abstract: The present invention relates to compositions and methods for preventing the development of epithelial ovarian cancer by administering compounds in an amount capable of increasing TGF-&bgr; expression in the ovarian epithelium. HRT and OCP regimens comprising such compositions and methods are disclosed.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: January 28, 2003
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of a vitamin D compound
    Patent number: 6444658
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: September 3, 2002
    Assignee: New Life Pharmaceuticals Inc.
    Inventors: Gustavo C. Rodriguez, Regina Salas Whitaker
  • Prevention of ovarian cancer by administration of a vitamin D compound
    Patent number: 6407082
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering a Vitamin D compound in an amount capable of increasing apoptosis in non-neoplastic ovarian epithelial cells of the female subject.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: June 18, 2002
    Assignee: New Life Pharmaceuticals Inc.
    Inventors: Gustavo C. Rodriguez, Regina Salas Whitaker
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6319911
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: July 16, 1998
    Date of Patent: November 20, 2001
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez
  • Prevention of ovarian cancer by administration of progestin products
    Patent number: 6310054
    Abstract: The present invention relates to methods for preventing the development of epithelial ovarian cancer by administering progestin products, either alone or in combination with other agents such as estrogen products.
    Type: Grant
    Filed: December 16, 1999
    Date of Patent: October 30, 2001
    Assignee: New Life Pharmaceuticals Inc.
    Inventor: Gustavo C. Rodriguez